1. Home
  2. RRGB vs ATYR Comparison

RRGB vs ATYR Comparison

Compare RRGB & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RRGB

Red Robin Gourmet Burgers Inc.

HOLD

Current Price

$3.63

Market Cap

69.1M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.84

Market Cap

77.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRGB
ATYR
Founded
1969
2005
Country
United States
United States
Employees
N/A
58
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
77.0M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
RRGB
ATYR
Price
$3.63
$0.84
Analyst Decision
Strong Buy
Hold
Analyst Count
3
9
Target Price
$9.00
$3.67
AVG Volume (30 Days)
236.8K
829.1K
Earning Date
05-28-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
73.43
N/A
EPS
N/A
N/A
Revenue
$1,315,014,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.46
$0.64
52 Week High
$7.52
$7.29

Technical Indicators

Market Signals
Indicator
RRGB
ATYR
Relative Strength Index (RSI) 49.07 52.75
Support Level $3.20 $0.82
Resistance Level $4.41 $0.86
Average True Range (ATR) 0.27 0.04
MACD -0.03 0.00
Stochastic Oscillator 19.49 69.95

Price Performance

Historical Comparison
RRGB
ATYR

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: